Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women.
Vaginal rings releasing progesterone with 3 different initial release rates (5, 8 and 20 mg/day) were used by 11, 10 and 10 women, respectively. The period of insertion was 90 days. The 5 and 8 mg/day rings consisted of a core loaded with progesterone, the 20 mg/day ring contained progesterone homogeneously distributed throughout the mass of the ring. Notwithstanding these differences, the total progesterone levels (areas under curve) were directly related to the release rates. So were the rates of decrease of progesterone levels during the 90 days of insertion of the ring. They were 25, 31 and 47% for the rings releasing 5, 8 and 20 mg/day, respectively.
Landgren
B M
BM
Department of Obstetrics and Gynaecology, Karolinska Hospital, Stockholm, Sweden.
Hall
P E
PE
Cekan
S Z
SZ
D000282:Administration, Intravaginal; D000328:Adult; D003274:Contraceptive Devices, Female; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D011374:Progesterone / Q000493:pharmacokinetics*; D011863:Radioimmunoassay
D011374:Progesterone